(Q37937069)

25 August 2017

title

Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis (English)

1 reference

25 August 2017

0 references

Sheetal Patil

1

1 reference

25 August 2017

Magdalena Anitescu

series ordinal

2

1 reference

25 August 2017

publication date

21 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

263-269

1 reference

Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

The role of ketamine in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Ketamine in chronic pain management: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Ketamine patient-controlled analgesia for dysesthetic central pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Intravenous treatment of chronic daily headaches in the outpatient headache clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Early use of memantine for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01241.X

10.1111/J.1526-4637.2011.01241.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference